- Home
- WNW vs INM Comparison
WNW vs INM Comparison
Compare WNW & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNW
- INM
- Stock Information
- Founded
- WNW 2015
- INM 1981
- Country
- WNW China
- INM Canada
- Employees
- WNW N/A
- INM N/A
- Industry
- WNW Catalog/Specialty Distribution
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- WNW Consumer Discretionary
- INM Health Care
- Exchange
- WNW Nasdaq
- INM Nasdaq
- Market Cap
- WNW 5.4M
- INM 4.4M
- IPO Year
- WNW 2020
- INM N/A
- Fundamental
- Price
- WNW $1.86
- INM $2.11
- Analyst Decision
- WNW
- INM
- Analyst Count
- WNW 0
- INM 0
- Target Price
- WNW N/A
- INM N/A
- AVG Volume (30 Days)
- WNW 11.9K
- INM 42.3K
- Earning Date
- WNW 05-14-2025
- INM 09-29-2025
- Dividend Yield
- WNW N/A
- INM N/A
- EPS Growth
- WNW N/A
- INM N/A
- EPS
- WNW 9.06
- INM N/A
- Revenue
- WNW $158,485.00
- INM $4,920,990.00
- Revenue This Year
- WNW N/A
- INM N/A
- Revenue Next Year
- WNW N/A
- INM N/A
- P/E Ratio
- WNW $0.21
- INM N/A
- Revenue Growth
- WNW N/A
- INM N/A
- 52 Week Low
- WNW $0.95
- INM $1.72
- 52 Week High
- WNW $70.00
- INM $8.27
- Technical
- Relative Strength Index (RSI)
- WNW 58.73
- INM 35.28
- Support Level
- WNW $1.67
- INM $2.22
- Resistance Level
- WNW $1.76
- INM $2.25
- Average True Range (ATR)
- WNW 0.10
- INM 0.08
- MACD
- WNW 0.01
- INM 0.00
- Stochastic Oscillator
- WNW 86.44
- INM 26.67
About WNW Meiwu Technology Company Limited
Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.